You are here

Article info

Article menu

Download PDFPDF

XML
Hypothesis
Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?

Authors

  • Catalin Constantinescu Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania Department of Anesthesia - Intensive Care, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania PubMed articlesGoogle scholar articles
  • Sergiu Pasca Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania PubMed articlesGoogle scholar articles
  • Tiberiu Tat Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania PubMed articlesGoogle scholar articles
  • Patric Teodorescu Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania PubMed articlesGoogle scholar articles
  • Catalin Vlad Department of Surgery, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania PubMed articlesGoogle scholar articles
  • Sabina Iluta Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania PubMed articlesGoogle scholar articles
  • Delia Dima Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania PubMed articlesGoogle scholar articles
  • Dana Tomescu Department of Anesthesia - Intensive Care, Carol Davila University of Medicine and Pharmacy, Bucuresti, Romania Department of Anesthesia - Intensive Care, Fundeni Clinical Institute, Bucuresti, Romania PubMed articlesGoogle scholar articles
  • Ecaterina Scarlatescu Department of Stem Cell Transplantation, Clinical Institute Fundeni, Bucuresti, Romania PubMed articlesGoogle scholar articles
  • Alina Tanase Department of Stem Cell Transplantation, Clinical Institute Fundeni, Bucuresti, Romania PubMed articlesGoogle scholar articles
  • Olafur Eysteinn Sigurjonsson University of Reykjavik, Reykjavik, Iceland Bloodbank, Landspitali National University Hospital of Iceland, Reykjavik, Iceland PubMed articlesGoogle scholar articles
  • Anca Colita Department of Stem Cell Transplantation, Clinical Institute Fundeni, Bucuresti, Romania PubMed articlesGoogle scholar articles
  • Hermann Einsele Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Wurzburg, Bayern, Germany PubMed articlesGoogle scholar articles
  • Ciprian Tomuleasa Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ciprian Tomuleasa; ciprian.tomuleasa{at}umfcluj.ro
View Full Text

Citation

Constantinescu C, Pasca S, Tat T, et al
Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
Journal for ImmunoTherapy of Cancer 2020;8:e000742. doi: 10.1136/jitc-2020-000742

Publication history

  • Accepted April 29, 2020
  • First published May 30, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.